SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 28th, 2017 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 24, 2017, by and between Propanc Biopharma, Inc., a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124 Australia (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 110 Wall Street, 3rd Floor, Suite 5-070, New York, NY 10005 (the “Buyer”).
